The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested close to $200 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Discover how the Maryland Stem Cell Research Fund Accelerates Cures here.
Below is a list of our most current awardees.
2025
Therapeutic Targets in Microglia for Prevention and Treatment of GBA1-Associated Parkinson's Disease
2023
Novel use of Peripheral Blood-Derived Cells to Identify Individuals at High Risk of Developing PD
2021
New Therapeutic Targets for Prevention and Treatment of GBA1-Associated Parkinson's Disease
Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.